Misoprostol and estradiol to enhance visualization of the transformation zone during cervical cancer screening: An integrative review.

MLA

Manga, Simon M., et al. “Misoprostol and Estradiol to Enhance Visualization of the Transformation Zone during Cervical Cancer Screening: An Integrative Review.” European Journal of Obstetrics & Gynecology & Reproductive Biology, vol. 269, Feb. 2022, pp. 16–23. EBSCOhost, https://doi.org/10.1016/j.ejogrb.2021.11.431.

APA

Manga, S. M., Kincaid, K. D., Boitano, T. K. L., Tita, A. T., Scarinci, I. C., Huh, W. K., & Liang, M. I. (2022). Misoprostol and estradiol to enhance visualization of the transformation zone during cervical cancer screening: An integrative review. European Journal of Obstetrics & Gynecology & Reproductive Biology, 269, 16–23. https://doi.org/10.1016/j.ejogrb.2021.11.431

Chicago

Manga, Simon M., Kaitlyn D. Kincaid, Teresa K.L. Boitano, Alan T. Tita, Isabel C. Scarinci, Warner K. Huh, and Margaret I. Liang. 2022. “Misoprostol and Estradiol to Enhance Visualization of the Transformation Zone during Cervical Cancer Screening: An Integrative Review.” European Journal of Obstetrics & Gynecology & Reproductive Biology 269 (February): 16–23. doi:10.1016/j.ejogrb.2021.11.431.